NuCana BioMed Limited - Product Pipeline Review - 2015

  • ID: 3429806
  • Company Profile
  • 32 pages
  • Global Markets Direct
1 of 4
NuCana BioMed Limited - Product Pipeline Review - 2015

Summary

The report ‘NuCana BioMed Limited - Product Pipeline Review - 2015’, provides an overview of the NuCana BioMed Limited’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of NuCana BioMed Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of NuCana BioMed Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of NuCana BioMed Limited’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the NuCana BioMed Limited’s pipeline products

Reasons to buy

- Evaluate NuCana BioMed Limited’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of NuCana BioMed Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the NuCana BioMed Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of NuCana BioMed Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of NuCana BioMed Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of NuCana BioMed Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

NuCana BioMed Limited Snapshot

NuCana BioMed Limited Overview

Key Information

Key Facts

NuCana BioMed Limited - Research and Development Overview

Key Therapeutic Areas

NuCana BioMed Limited - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

NuCana BioMed Limited - Pipeline Products Glance

NuCana BioMed Limited - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

NuCana BioMed Limited - Early Stage Pipeline Products

IND/CTA Filed Products/Combination Treatment Modalities

Preclinical Products/Combination Treatment Modalities

NuCana BioMed Limited - Drug Profiles

NUC-1031

Product Description

Mechanism of Action

R&D Progress

NUC-3373

Product Description

Mechanism of Action

R&D Progress

NUC-7738

Product Description

Mechanism of Action

R&D Progress

NUC-4545

Product Description

Mechanism of Action

R&D Progress

NUC-5435

Product Description

Mechanism of Action

R&D Progress

NUC-6285

Product Description

Mechanism of Action

R&D Progress

NUC-9000

Product Description

Mechanism of Action

R&D Progress

NUC-9324

Product Description

Mechanism of Action

R&D Progress

NuCana BioMed Limited - Pipeline Analysis

NuCana BioMed Limited - Pipeline Products by Target

NuCana BioMed Limited - Pipeline Products by Route of Administration

NuCana BioMed Limited - Pipeline Products by Molecule Type

NuCana BioMed Limited - Pipeline Products by Mechanism of Action

NuCana BioMed Limited - Recent Pipeline Updates

NuCana BioMed Limited - Dormant Projects

NuCana BioMed Limited - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

NuCana BioMed Limited, Key Information

NuCana BioMed Limited, Key Facts

NuCana BioMed Limited - Pipeline by Indication, 2015

NuCana BioMed Limited - Pipeline by Stage of Development, 2015

NuCana BioMed Limited - Monotherapy Products in Pipeline, 2015

NuCana BioMed Limited - Phase II, 2015

NuCana BioMed Limited - Phase I, 2015

NuCana BioMed Limited - IND/CTA Filed, 2015

NuCana BioMed Limited - Preclinical, 2015

NuCana BioMed Limited - Pipeline by Target, 2015

NuCana BioMed Limited - Pipeline by Route of Administration, 2015

NuCana BioMed Limited - Pipeline by Molecule Type, 2015

NuCana BioMed Limited - Pipeline Products by Mechanism of Action, 2015

NuCana BioMed Limited - Recent Pipeline Updates, 2015

NuCana BioMed Limited - Dormant Developmental Projects,2015

List of Figures

NuCana BioMed Limited - Pipeline by Top 10 Indication, 2015

NuCana BioMed Limited - Pipeline by Stage of Development, 2015

NuCana BioMed Limited - Monotherapy Products in Pipeline, 2015

NuCana BioMed Limited - Pipeline by Top 10 Target, 2015

NuCana BioMed Limited - Pipeline by Top 10 Route of Administration, 2015

NuCana BioMed Limited - Pipeline by Top 10 Molecule Type, 2015

NuCana BioMed Limited - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll